Therapeutic modulation of PPAR (gamma) activity

Details for Australian Patent Application No. 2005221140 (hide)

Owner Amgen Inc.

Inventors Chen, Jin-Long

Agent Spruson & Ferguson

Pub. Number AU-A-2005221140

PCT Pub. Number WO2005/086904

Priority 60/551,656 08.03.04 US

Filing date 7 March 2005

Wipo publication date 22 September 2005

International Classifications

A61K 31/425 (2006.01) - Thiazoles

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/086904 Priority application(s): WO2005/086904

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221142-Dependency graph parameter scoping

2005221138-Ion channel modulators